Editorial
Prognostic factors of patients with pathologic stage I lung adenocarcinoma
Abstract
Lung cancer remains one of the most common causes of cancer-related deaths worldwide. Increasingly more research is aimed at investigating the clinicopathologic parameters or gene mutations involved in the survival of patients with lung cancer.
